Welcome
Pharmaceutical & Life Sciences News

J&J to Accelerate Development of Potential Coronavirus Vaccine

Feb. 11, 2020, 9:34 PM

J&J’s Janssen Pharmaceutical will further expedite its investigational coronavirus vaccine program through an expanded collaboration with the Biomedical Advanced Research and Development Authority.

  • The collaborative partnership with BARDA builds on Johnson & Johnson’s multipronged response to the new coronavirus disease outbreak.
  • Janssen and BARDA will both contribute to R&D costs and mobilize resources to rapidly advance the initial stages of Janssen’s COVID-19 vaccine development program

To view the source of this information click here

To contact the reporter on this story:
Hari Govind in San Francisco at hgovind@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net...

To read the full article log in. To learn more about a subscription click here.